VTR Biotech successfully participated in VIV Asia 2025, one of the premier international events for the animal feed and ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...

Apollomics has sold the rights to its lead c-MET inhibitor in Asia, excluding Greater China ... The Foster City, Calif.-based biotech had already given up hope for the therapy, from which it ...

(MENAFN- IANS) New Delhi, March 31 (IANS) Biotechnology remains a priority sector in India, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh on Monday.

organizations and technologies across Asia. The awards aim to foster the advancement of the biopharmaceutical industry. Amaran Biotech’s high-purity AB-801 adjuvant, produced through its ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology buzzwords and hype have lost their shine in pharma, and the spotlight is now ...

The biotechnology sector is inherently volatile, influenced by several key industry factors. Clinical trial outcomes are a major driver of stock price fluctuations, as success or failure can ...